Drugs / BCD-033
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT02727907 | Feb 2015 → Nov 2016 | multiple sclerosis | Biocad | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCD-033 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02727907 ↗ |
| Known as | interferon beta 1a | “BCD-033 (interferon beta 1a)” NCT02727907 ↗ |
| Route | Subcutaneous | “Subcutaneous injection of BCD-033” NCT02727907 ↗ |